Metraipolis › archive › dc_abc6003cddca

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of… — Europe PMC PMID:42434738

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42434738
DOI: 10.3389/fonc.2026.1865991
License (as archived): solo-consultazione
Archived: 2026-10-31T08:41:09.258Z
SHA-256 of the archived text: 9d0813fe250395c3ec596aff3e80fbfe743cdf05ea67db67fe2b0edf11a10056
Stable URL of this page: https://metraipolis.com/documento/dc_abc6003cddca

How to cite

Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of… — Europe PMC PMID:42434738 — Europe PMC (en), https://europepmc.org/article/MED/42434738 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_abc6003cddca (Metraipolis archive dc_abc6003cddca, sha256 9d0813fe250395c3ec596aff3e80fbfe743cdf05ea67db67fe2b0edf11a10056)

BibTeX

@misc{dcabc6003cddca,
  title = {Clinical efficacy and safety of pembrolizumab and nivolumab in frontline treatment for classical Hodgkin lymphoma: systematic review and meta-analysis of… — Europe PMC PMID:42434738},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42434738},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_abc6003cddca; sha256 9d0813fe250395c3ec596aff3e80fbfe743cdf05ea67db67fe2b0edf11a10056},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42434738. Agents can read the archived copy with the MCP tool read_document.